SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-24-051177
Filing Date
2024-02-29
Accepted
2024-02-28 19:49:14
Documents
11

Document Format Files

Seq Description Document Type Size
1 S-3 d736472ds3.htm S-3 509586
2 EX-1.2 d736472dex12.htm EX-1.2 191875
3 EX-4.5 d736472dex45.htm EX-4.5 299875
4 EX-4.7 d736472dex47.htm EX-4.7 94294
5 EX-4.8 d736472dex48.htm EX-4.8 98611
6 EX-4.9 d736472dex49.htm EX-4.9 84287
7 EX-5.1 d736472dex51.htm EX-5.1 30258
8 EX-23.1 d736472dex231.htm EX-23.1 1807
9 EX-FILING FEES d736472dexfilingfees.htm EX-FILING FEES 53516
10 GRAPHIC g736472dsp008.jpg GRAPHIC 3001
11 GRAPHIC g736472g01a04.jpg GRAPHIC 41059
  Complete submission text file 0001193125-24-051177.txt   1426104
Mailing Address 201 HASKINS WAY SOUTH SAN FRANCISCO CA 94080
Business Address 201 HASKINS WAY SOUTH SAN FRANCISCO CA 94080 650 695-0677
Lyell Immunopharma, Inc. (Filer) CIK: 0001806952 (see all company filings)

IRS No.: 833006753 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-277495 | Film No.: 24698182
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)